November 2020 FDA Recall Drug by Invatech Pharma Solutions, Llc
D-0115-2021 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Invatech Pharma Solutions, Llc on November 11, 2020 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0115-2021

Reason for Recall
Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.
Initiated
11-11-2020
Reported
12-09-2020
Quantity
N/A

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
InvaTech Pharma Solutions, LLC
Distributed Nationwide in the USA
Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc. New Castle, DE 19720. NDC 10135-0639-30

Batch or Lot Expiration Information

Lot# : 051944A Exp. Date April - 2021; 1119124 Exp Date Oct - 2021; 062088 Exp Date June - 2022